Related Experiment Video
Updated: Jun 17, 2025

07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
2.4K
Adapt and shape: metabolic features within the metastatic niche
Erica Pranzini1, Luigi Ippolito1, Elisa Pardella1
1Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Morgagni, 50, 50134 Firenze, (FI), Italy.
Trends in Endocrinology and Metabolism: TEM
|August 9, 2024
Summary
Metabolic factors influence cancer cell metastasis. Primary tumors condition distant sites, and disseminating cancer cells (DTCs) adapt their metabolism for survival and colonization, impacting metastatic success.
Area of Science:
- Oncology
- Cancer Biology
- Metabolism
Background:
- Metabolic factors significantly influence the success of disseminating cancer cells (DTCs) at specific metastatic sites.
- The primary tumor can metabolically condition distant organs, creating a premetastatic niche before DTCs arrive.
- DTCs also adapt their metabolism to survive the metastatic journey and colonize target organs.
Purpose of the Study:
- To review how cancer cells interact with the metabolic environment of target organs.
- To explore the dual strategies cancer cells employ to shape or adapt to tissue metabolism for metastasis.
- To highlight the underestimated role of target organ metabolism in metastatic fate.
Main Methods:
- Literature review of existing studies on cancer cell metabolism and metastasis.
- Analysis of metabolic interplay between primary tumors, DTCs, and metastatic microenvironments.
- Synthesis of findings on cancer cell strategies for metabolic adaptation and tissue shaping.
Main Results:
- Cancer cells utilize distinct metabolic strategies to colonize target tissues.
- These strategies involve both altering the host tissue's metabolism and adapting their own metabolic pathways.
- Successful colonization relies on creating a metabolically favorable environment for tumor growth.
Conclusions:
- Metabolic reprogramming is crucial at multiple stages of cancer metastasis.
- Both the origin (primary tumor) and the destination (target organ) play significant metabolic roles.
- Understanding these metabolic dynamics offers potential therapeutic targets for preventing or treating metastasis.
Related Concept Videos
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K

